Addition of ultrasound and MRI fusion–targeted biopsy enhances systemic prostate biopsy
August 10th 2023A recent study suggests that combined use of ultrasound and multiparametric MRI-targeted biopsy with systematic biopsy may be more effective for detecting clinically significant prostate cancers than using systematic biopsies alone
MRI-guided SBRT associated with lower GU/GI toxicity vs CT-guided SBRT in prostate cancer
July 28th 2023“These findings suggest that the technical advantages of precision of radiotherapy delivery afforded by MRg-A-SBRT translate to measurable clinical benefit,” wrote lead study author Jonathan E. Leeman, MD.
PSMA-PET–determined disease extent emerges as potential prognostic marker in high-risk nmCRPC
June 19th 2023Pelvic lymph node involvement and polymetastases detected with PSMA-PET imaging were linked to significantly lower overall survival rates in patients initially diagnosed with non-metastatic, castration-resistant prostate based on conventional imaging.
Study highlights efficacy of prostate artery embolization in BPH
March 5th 2023“This study shows prostate artery embolization to be a safe and highly effective treatment whose long-term outcomes include sustained LUTS relief, significant improvement in quality of life and no change in erectile function,” according to Shivank Bhatia, MD.
Researchers advocate ultrasound over CT for initial evaluation of suspected urinary stone disease
November 7th 2022The study authors maintain there is no current evidence in the literature indicating that CT use is superior to other imaging modalities in reducing morbidity or improving outcomes in patients with urinary stone disease.